AusperBio secures USD 37Mln in series A financing

AusperBio Secures $37 Million in Series A Financing to Advance AHB-137 Clinical Development for HBV Cure

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic hepatitis B (CHB) infection, yesterday announced the completion of a $37 million Series A financing round. This round was led by existing investor, InnoPinnacle Fund, with participation from new […]

MTF Biologics and Centurion partner to advance wound care technologies

MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advance Wound Care Technologies

MTF Biologics, a global leader in tissue-based solutions, and Centurion Therapeutics, a pioneering distributor in the medical field, yesterday announced they have entered into a new agreement that will give more clinicians and patients in complex wound settings within hospitals and post-acute care facilities access to advanced wound healing technologies. The agreement, which is an expansion […]

Veristat Appoints Gabriela Rosu, M.D., as Senior Director of Global Medical Affairs Team

Veristat, the Science-First Full Service CRO and Consultancy announced that Gabriela Rosu, M.D., has joined as Senior Director of Global Medical Affairs. Dr Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval […]